1.39
Chemomab Therapeutics Ltd Adr Stock (CMMB) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2023-03-31 |
Period Length | 3 Months |
|
|
Income/Loss From Continuing Operations Before Tax | |
Income Tax Expense/Benefit | |
Income/Loss From Continuing Operations After Tax | |
|
|
Preferred Stock Dividends And Other Adjustments | |
Attributable To Noncontrolling Interest | |
Basic Average Shares | |
Diluted Average Shares | |
Basic Earnings Per Share | |
Diluted Earnings Per Share | |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):